Etienne Daguindau

6PUBLICATIONS
100CO-AUTHORS
HaematologyPredictive and prognostic markersMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 19, 2026
Eltrombopag Added to Standard Immunosuppressive Treatment as Front-Line Therapy for Severe Aplastic Anemia: Long-Term Outcomes of the Phase-3 Randomized Superiority EBMT-SAAWP RACE Study.

|Jun 13, 2025
Overall Survival After Allogeneic Transplantation in Advanced Cutaneous T-Cell Lymphomas (CUTALLO): A Propensity Score-Matched Controlled Prospective Study.

Adèle de Masson, Marie Beylot-Barry, Caroline Ram-Wolff

|Feb 14, 2025
HLA evolutionary divergence score after donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation.

Sophie Le Grand, Juliette Villemonteix, Etienne Daguindau

|May 31, 2024
Impact of scFv on Functionality and Safety of Third-Generation CD123 CAR T Cells.

Maxime Fredon, Margaux Poussard, Sabeha Biichlé

|Mar 06, 2023
Impact of allele-level HLA matching on outcomes after double cord blood transplantation in adults with malignancies.

Giancarlo Fatobene, Livia Mariano, Fernanda Volt

|Jan 17, 2022
High-density lipoprotein infusion protects from acute graft-versus-host disease in experimental allogeneic hematopoietic cell transplantation.

Cécile Chagué, Thomas Gautier, Ludivine Dal Zuffo

Pageof 1

Frequent Collaborators

4 joint publications

Régis Peffault de Latour

2 joint publications

David Michonneau

2 joint publications

Edouard Forcade

2 joint publications

Christian Recher